Clinical Trial

A Study of Cizutamig in Systemic Sclerosis

Name: A Study of Cizutamig in Systemic Sclerosis — clinical trial record (NCT07158996)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Early Phase 1

View on ClinicalTrials.gov →

Summary

The purpose of this study is to assess the safety, tolerability, PK, PD, immunogenicity, and preliminary clinical activity of cizutamig in patients with SSc.

Trial Details

NCT Number	NCT07158996
Lead Sponsor	Ruijin Hospital
Conditions	Systemic Sclerosis (SSc)
Enrollment	10 participants
Start Date	2025-09-04
Primary Completion	2026-12-01 (estimated)
Study Completion	2027-08-31 (estimated)
Updated on ClinicalTrials.gov	2025-09-08